Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells

被引:13
作者
Hamill, C. A. [1 ]
Michaelson, J. S. [2 ]
Hahm, Kyungmin [2 ]
Burkly, Linda C. [2 ]
Kessler, J. A. [1 ]
机构
[1] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA
[2] Biogen Idec, Dept Mol Discovery, Cambridge, MA USA
关键词
axon elongation; cytokine; proliferation; neural progenitor cells;
D O I
10.1002/jnr.21443
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
TWEAK/Fn14 signaling regulates progenitor cell proliferation, differentiation, and survival in multiple organ systems. This study examined the effects of TWEAK (tumor necrosis factor-like weak inducer of apoptosis) treatment on cultured mouse neural progenitor cells. The receptor for TWEAK is expressed by neural progenitor cells from the early embryonic stages through postnatal development. Although embryonic day 12 (E12) and postnatal day 1 (PN1) neural progenitor cells both express the receptor for TWEAK, TWEAK treatment of cultured E12 and PN1 progenitor cells resulted in age-dependent effects on proliferation and on neurite extension by neuronal progeny. TWEAK treatment did not alter proliferation of E12 neural progenitor cells but shifted PN1 progenitor cells toward cell-cycle phases GO and G1 and reduced the rate at which they incorporated CldU. Conversely, the effects of TWEAK on axon elongation were more prominent in the earlier developmental stage. TWEAK induced extensive neurite outgrowth by the neuronal progeny of E12 but not PN1 progenitors. Treatment of the E12 progenitor cells with a TWEAK-neutralizing antibody repressed neurite extension, indicating that enclogenous activation of this pathway may be required for neurite extension by the embryonic neuronal progeny. These studies indicate that TWEAK/Fn14 receptor activation exerts different effects on neural progenitor cells and their progeny depending on the developmental stage of the cells. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:3535 / 3544
页数:10
相关论文
共 48 条
  • [31] TWEAK is a novel arthritogenic mediator
    Perper, Stuart J.
    Browning, Beth
    Burkly, Linda C.
    Weng, Shawn
    Gao, Cindy
    Giza, Keith
    Su, Lihe
    Tarilonte, Leticia
    Crowell, Thomas
    Rajman, Luis
    Runkel, Laura
    Scott, Martin
    Atkins, Gerald J.
    Findlay, David M.
    Zheng, Timothy S.
    Hess, Henry
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (04) : 2610 - 2620
  • [32] Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration
    Potrovita, I
    Zhang, W
    Burkly, L
    Hahm, K
    Lincecum, J
    Wang, MZ
    Maurer, MH
    Rossner, M
    Schneider, A
    Schwaninger, M
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (38) : 8237 - 8244
  • [33] Neural stem cells and neurospheres - re-evaluating the relationship
    Reynolds, BA
    Rietze, RL
    [J]. NATURE METHODS, 2005, 2 (05) : 333 - 336
  • [34] Saas P, 2000, GLIA, V32, P102, DOI 10.1002/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO
  • [35] 2-U
  • [36] TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation
    Saitoh, T
    Nakayama, M
    Nakano, H
    Yagita, H
    Yamamoto, N
    Yamaoka, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) : 36005 - 36012
  • [37] Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO
  • [38] 2-U
  • [39] Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms
    Sun, Y
    Nadal-Vicens, M
    Misono, S
    Lin, MZ
    Zubiaga, A
    Hua, XX
    Fan, GP
    Greenberg, ME
    [J]. CELL, 2001, 104 (03) : 365 - 376
  • [40] DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain
    Takizawa, T
    Nakashima, K
    Namihira, M
    Ochiai, W
    Uemura, A
    Yanagisawa, M
    Fujita, N
    Nakao, M
    [J]. DEVELOPMENTAL CELL, 2001, 1 (06) : 749 - 758